Your browser doesn't support javascript.
The association between metformin treatment and COVID-19 outcomes according to metformin continuation during hospitalisation.
Al-Salameh, Abdallah; Bennis, Youssef; Cariou, Bertrand; Lalau, Jean-Daniel.
  • Al-Salameh A; Department of Endocrinology- Diabetes Mellitus and Nutrition, Amiens University Hospital, Amiens, France; PériTox, UMR_I 01, University of Picardie Jules Verne, Amiens, France. Electronic address: Al-Salameh.Abdallah@chu-amiens.fr.
  • Bennis Y; Department of Clinical Pharmacology, Amiens University Hospital, Amiens, France; MP3CV Laboratory, UR UPJV 7517, University of Picardie Jules Verne, Amiens, France.
  • Cariou B; Département d'Endocrinologie, Diabétologie et Nutrition, l'institut du thorax, Inserm, CNRS, UNIV Nantes, CHU Nantes, Hôpital Guillaume et René Laennec, 44093 Nantes Cedex 01, France.
  • Lalau JD; Department of Endocrinology- Diabetes Mellitus and Nutrition, Amiens University Hospital, Amiens, France; PériTox, UMR_I 01, University of Picardie Jules Verne, Amiens, France. Electronic address: Lalau.Jean-Daniel@chu-amiens.fr.
Diabetes Metab ; 47(6): 101297, 2021 11.
Article in English | MEDLINE | ID: covidwho-1474469
Subject(s)
Keywords
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Drug Treatment / Metformin Type of study: Prognostic study Limits: Humans Language: English Journal: Diabetes Metab Journal subject: Endocrinology / Metabolism Year: 2021 Document Type: Article

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Drug Treatment / Metformin Type of study: Prognostic study Limits: Humans Language: English Journal: Diabetes Metab Journal subject: Endocrinology / Metabolism Year: 2021 Document Type: Article